Identification of a Unique Inhibitor-Binding Site on Choline Kinase α
- Univ. of Illinois at Chicago, IL (United States)
- Univ. of Pennsylvania, Philadelphia, PA (United States)
- Univ. of Illinois at Chicago, IL (United States); The Jesse Brown VA Medical Center, Chicago, IL (United States)
Choline kinase α (ChoKα) is an enzyme that is upregulated in many types of cancer and has been shown to be tumorigenic. As such, it makes a promising target for inhibiting tumor growth. Though there have been several inhibitors synthesized for ChoKα, not all of them demonstrate the same efficacy in vivo, though the reasons behind this difference in potency are not clear. One particular inhibitor, designated TCD-717, has recently completed phase I clinical trials. Cell culture and in vitro studies support the powerful inhibitory effect TCD-717 has on ChoKα, but an examination of the inhibitor’s interaction with the ChoKα enzyme has been missing prior to this work. Here we detail the 2.35 Å structure of ChoKα in complex with TCD-717. Examination of this structure in conjunction with kinetic assays reveals that TCD-717 does not bind directly in the choline pocket as do previously characterized ChoKα inhibitors, but rather in a proximal but novel location near the surface of the enzyme. Here, the unique binding site identified for TCD-717 lends insight for the future design of more potent in vivo inhibitors for ChoKα.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; National Inst. of Health
- Grant/Contract Number:
- AC02-06CH11357; 085P1000817; RO1 EB013685; R01 EB018645
- OSTI ID:
- 1432889
- Journal Information:
- Biochemistry, Vol. 57, Issue 8; ISSN 0006-2960
- Publisher:
- American Chemical Society (ACS)Copyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Web of Science
Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase
|
journal | November 2019 |
Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer
|
journal | August 2018 |
Causes, consequences, and therapy of tumors acidosis
|
journal | March 2019 |
Similar Records
Studies on (/sup 3/H) hemicholinium-3 ((/sup 3/H)HC-3), (/sup 3/H) pirenzepine ((/sup 3/H)PZ) and (/sup 3/H)(-)quinuclidinyl benzilate ((/sup 3/H)(-)QNB) binding with choline and acetylcholine analogues (AF30, AF64, AF64A)
Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase